UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Interpretation of kidney stone analysis

Author
Gary C Curhan, MD, ScD
Section Editor
Glenn M Preminger, MD
Deputy Editor
Albert Q Lam, MD

INTRODUCTION

Kidney stones can contain a variety of crystalline and noncrystalline materials. Knowing the composition of a stone influences clinical decisions. Although the 24-hour urine composition provides information on the possible composition of a patient's stone, this is not perfectly predictive of the stone type and, at times, can be misleading. Thus, instructing the patient to retrieve a passed stone or instructing the urologist, who is performing a stone-related procedure, to save and send a stone fragment for analysis is an important part of the approach to prevent recurrent stone formation. The stone composition may also influence the choice of urologic intervention.

The most common crystalline materials found in kidney stones are calcium oxalate, calcium phosphate, uric acid, and struvite. It is not uncommon for a stone to contain more than one crystalline component. Noncrystalline materials found in stones include proteins and blood. Some laboratories report the composition of the nidus (if present) separately from the composition of the body of the stone.

INDIVIDUAL CRYSTALLINE COMPONENTS

Calcium oxalate — Calcium oxalate is the most common component found in kidney stones (approximately 70 to 80 percent). Calcium oxalate can be found in monohydrate (crystal name: whewellite) and dihydrate (crystal name: weddellite) forms (picture 1). Calcium oxalate can also be present in combination with uric acid or calcium phosphate. Because calcium oxalate stones typically grow on a Randall's plaque (composed of calcium phosphate) on the papillary tip [1,2], a laboratory that examines the composition of the nidus may report a stone with an eccentric calcium phosphate nidus (usually 5 percent) and a calcium oxalate body (95 percent).

Urinary risk factors for calcium oxalate crystal formation are lower urine volume, higher urine calcium excretion, higher urine oxalate excretion, and lower urine citrate excretion. Calcium oxalate crystals are pH insensitive in the physiologic pH range of 5 to 8. (See "Risk factors for calcium stones in adults".)

Calcium phosphate — Calcium phosphate is found in approximately 15 percent of kidney stones and can be present in combination with calcium oxalate or struvite. Because of differences in solubility due to urine pH, calcium phosphate is not found mixed with uric acid. The two forms of calcium phosphate include apatite (sometimes reported as carbonate apatite), which is the crystal type found in bone, or calcium hydrogen phosphate (brushite); the frequency of apatite is much greater than brushite.

        

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Tue Oct 20 00:00:00 GMT+00:00 2015.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Miller NL, Williams JC Jr, Evan AP, et al. In idiopathic calcium oxalate stone-formers, unattached stones show evidence of having originated as attached stones on Randall's plaque. BJU Int 2010; 105:242.
  2. Miller NL, Gillen DL, Williams JC Jr, et al. A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall's plaque. BJU Int 2009; 103:966.
  3. Bollée G, Dollinger C, Boutaud L, et al. Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency. J Am Soc Nephrol 2010; 21:679.
  4. Basiri A, Taheri M, Taheri F. What is the state of the stone analysis techniques in urolithiasis? Urol J 2012; 9:445.
  5. Krambeck AE, Khan NF, Jackson ME, et al. Inaccurate reporting of mineral composition by commercial stone analysis laboratories: implications for infection and metabolic stones. J Urol 2010; 184:1543.
  6. Viprakasit DP, Sawyer MD, Herrell SD, Miller NL. Changing composition of staghorn calculi. J Urol 2011; 186:2285.
  7. Mostafavi MR, Ernst RD, Saltzman B. Accurate determination of chemical composition of urinary calculi by spiral computerized tomography. J Urol 1998; 159:673.
  8. Marchini GS, Gebreselassie S, Liu X, et al. Absolute Hounsfield unit measurement on noncontrast computed tomography cannot accurately predict struvite stone composition. J Endourol 2013; 27:162.
  9. Hidas G, Eliahou R, Duvdevani M, et al. Determination of renal stone composition with dual-energy CT: in vivo analysis and comparison with x-ray diffraction. Radiology 2010; 257:394.
  10. Zilberman DE, Ferrandino MN, Preminger GM, et al. In vivo determination of urinary stone composition using dual energy computerized tomography with advanced post-acquisition processing. J Urol 2010; 184:2354.
  11. Kadlec AO, Fridirici ZC, Acosta-Miranda AM, et al. Bilateral urinary calculi with discordant stone composition. World J Urol 2014; 32:281.